ARHGEF17 polyclonal antibody
* The price is valid only in USA. Please select country.
-
More Files
- More Functions
-
Specification
Product Description
Rabbit polyclonal antibody raised against synthetic peptide of ARHGEF17.
Immunogen
A synthetic peptide corresponding to internal region 18 amino acids of human ARHGEF17.
Host
Rabbit
Reactivity
Human
Form
Liquid
Recommend Usage
Western Blot (1-2 ug/mL)
The optimal working dilution should be determined by the end user.Storage Buffer
In PBS (0.02% sodium azide)
Storage Instruction
Store at 4°C for three months. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.Note
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Applications
Western Blot (Cell lysate)
Western blot analysis of ARHGEF17 in Jurkat Cell lysate with ARHGEF17 polyclonal antibody (Cat # PAB13013) at (A) 1 and (B) 2 ug/mL .Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Immunohistochemistry of ARHGEF17 in human spleen tissue with ARHGEF17 polyclonal antibody (Cat # PAB13013) at 2.5 ug/mL . -
Gene Info — ARHGEF17
Entrez GeneID
9828Protein Accession#
Q96PE2Gene Name
ARHGEF17
Gene Alias
FLJ90019, KIAA0337, P164RHOGEF, TEM4, p164-RhoGEF
Gene Description
Rho guanine nucleotide exchange factor (GEF) 17
Gene Ontology
HyperlinkOther Designations
Rho-specific guanine-nucleotide exchange factor 164 kDa|tumor endothelial marker 4
-
Interactome
-
Disease
-
Publication Reference
-
A phase I and pharmacokinetic study of irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreated with 5-fluorouracil or raltitrexed.
Masi G, Falcone A, Di Paolo A, Allegrini G, Danesi R, Barbara C, Cupini S, Del Tacca M.
Clinical Cancer Research 2004 Mar; 10(5):1657.
-
Tumor endothelial markers: new targets for cancer therapy.
Nanda A, St Croix B.
Current Opinion in Oncology 2004 Jan; 16(1):44.
-
Cell surface tumor endothelial markers are conserved in mice and humans.
Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B.
Cancer Research 2001 Sep; 61(18):6649.
-
A phase I and pharmacokinetic study of irinotecan given as a 7-day continuous infusion in metastatic colorectal cancer patients pretreated with 5-fluorouracil or raltitrexed.
- +1-909-264-1399
+1-909-992-0619
Toll Free : +1-877-853-6098 - +1-909-992-3401
- sales@abnova.com